Correction: Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T1/T2 dual-weighted MRI and synergistic tumor diagnosis.
J Mater Chem B
; 11(40): 9765, 2023 Oct 18.
Article
em En
| MEDLINE
| ID: mdl-37814919
ABSTRACT
Correction for 'Hybrid lanthanide nanoparticles as a new class of binary contrast agents for in vivo T1/T2 dual-weighted MRI and synergistic tumor diagnosis' by Zhigao Yi et al., J. Mater. Chem. B, 2016, 4, 2715-2722, https//doi.org/10.1039/C5TB02375K.
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Diagnostic_studies
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article